- Home
- NEGG vs IMAB Comparison
NEGG vs IMAB Comparison
Compare NEGG & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- IMAB
- Stock Information
- Founded
- NEGG 2001
- IMAB 2014
- Country
- NEGG United States
- IMAB United States
- Employees
- NEGG N/A
- IMAB N/A
- Industry
- NEGG Other Specialty Stores
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- NEGG Consumer Discretionary
- IMAB Health Care
- Exchange
- NEGG Nasdaq
- IMAB Nasdaq
- Market Cap
- NEGG 75.6M
- IMAB 73.9M
- IPO Year
- NEGG 2010
- IMAB 2020
- Fundamental
- Price
- NEGG $4.01
- IMAB $0.88
- Analyst Decision
- NEGG
- IMAB Strong Buy
- Analyst Count
- NEGG 0
- IMAB 2
- Target Price
- NEGG N/A
- IMAB $5.50
- AVG Volume (30 Days)
- NEGG 33.3K
- IMAB 158.9K
- Earning Date
- NEGG 04-28-2025
- IMAB 04-03-2025
- Dividend Yield
- NEGG N/A
- IMAB N/A
- EPS Growth
- NEGG N/A
- IMAB N/A
- EPS
- NEGG N/A
- IMAB N/A
- Revenue
- NEGG $1,235,576,000.00
- IMAB N/A
- Revenue This Year
- NEGG N/A
- IMAB N/A
- Revenue Next Year
- NEGG N/A
- IMAB N/A
- P/E Ratio
- NEGG N/A
- IMAB N/A
- Revenue Growth
- NEGG N/A
- IMAB N/A
- 52 Week Low
- NEGG $3.32
- IMAB $0.60
- 52 Week High
- NEGG $26.40
- IMAB $2.00
- Technical
- Relative Strength Index (RSI)
- NEGG 45.45
- IMAB 52.85
- Support Level
- NEGG $3.40
- IMAB $0.83
- Resistance Level
- NEGG $4.20
- IMAB $0.92
- Average True Range (ATR)
- NEGG 0.31
- IMAB 0.07
- MACD
- NEGG 0.14
- IMAB 0.00
- Stochastic Oscillator
- NEGG 77.84
- IMAB 46.88
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).